The CD8+/FoxP3+ T cell ratio was commonly studied to predict the prognosis of patients and a meta-analysis indicated that a high CD8+/FoxP3+ T cell ratio was independently associated with improved survival based on the data from multiple cancer types [29]. Here, CD8A is linked to cancer.